Radiopaque and X‐ray‐Responsive Nanomedicine for Preventive Therapy of Radiation‐Induced Heart Disease
Small · 2023
DOI: 10.1002/smll.202303803 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2023. Verfasst von Mingchuan Yu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Rehabilitation Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, 330006, P. R. C…. Hauptthemen laut MEDLINE: Heart Diseases, Radiation Injuries. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Natural Science Foundation of Jiangxi Province.
Abstract (Originalsprache)
Radiation‐induced heart disease (RIHD) is a common radiotherapy complication. Reducing radiation exposure and post‐irradiation antioxidant therapy are promising approaches. Here, a liquid metal‐based core–shell nanomedicine (LMN) composed of a gallium core and a multifunctional polymeric shell with radiopaque, X‐ray shielding, and X‐ray‐responsive antioxidation properties for preventive therapy of RIHD is developed. The liquid metal provides radiopaque properties to enhance X‐ray and computed tomography imaging and attenuate radiation to prevent primary myocardial damage. Under X‐ray radiation, cleavage of the diselenide bond on the polymeric shell results in the release of LMN and controlled antioxidation. In vitro and in vivo experiments have demonstrated that LMN significantly reduces myocardial injury and impaired cardiac function, stabilizes mitochondrial function, and inhibits myocardial fibrosis. This nanomedicine with radiographic contrast, radiation shielding, and responsive features provides a new strategy for the prevention of radiation‐related diseases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Rehabilitation Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
- The Institute of Translational Medicine, the Second Affiliated Hospital of Nanchang University, Nanchang University, Nanchang, Jiangxi, 330006, P. R. China.
ORCID-Profile: Weichang Xie, Yu Liu
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Natural Science Foundation of Jiangxi Province
- Youth Science Foundation of Jiangxi Province
- Science and Technology Research Project of the Jiangxi Provincial Department of Education
- Incubation Program of National Natural Science Foundation of China of Second Affiliated Hospital of Nanchang University
Zitieren
APA
Yu, M., Xie, W., Tang, Z., Luo, J., & Liu, Y. (2023). Radiopaque and X‐ray‐Responsive Nanomedicine for Preventive Therapy of Radiation‐Induced Heart Disease. Small. https://doi.org/10.1002/smll.202303803
Vancouver
Yu M, Xie W, Tang Z, Luo J, Liu Y. Radiopaque and X‐ray‐Responsive Nanomedicine for Preventive Therapy of Radiation‐Induced Heart Disease. Small. 2023. doi:10.1002/smll.202303803
BibTeX
@article{Yu2023,
author = {Yu, Mingchuan and Xie, Weichang and Tang, Zhibo and Luo, Jun and Liu, Yu},
title = {Radiopaque and X‐ray‐Responsive Nanomedicine for Preventive Therapy of Radiation‐Induced Heart Disease},
journal = {Small},
year = {2023},
doi = {10.1002/smll.202303803}
}
EUVIMED